Minocycline : interactions médicamenteuses

Avoid concomitant use of isotretinoin and EMROSI because isotretinoin, a systemic retinoid, is also known to cause idiopathic intracranial hypertension. (notice Minocycline, Mises en garde et précautions)

Avoid concomitant use of isotretinoin and EMROSI because isotretinoin, a systemic retinoid, is also known to cause idiopathic intracranial hypertension. (notice Minocycline, Mises en garde et précautions)

Penicillin Because bacteriostatic drugs may interfere with the bactericidal action of penicillin, avoid giving EMROSI in conjunction with penicillin. (notice Minocycline, Interactions médicamenteuses)

Penicillin Because bacteriostatic drugs may interfere with the bactericidal action of penicillin, avoid giving EMROSI in conjunction with penicillin. (notice Minocycline, Interactions médicamenteuses)

Penicillin Because bacteriostatic drugs may interfere with the bactericidal action of penicillin, avoid giving EMROSI in conjunction with penicillin. (notice Minocycline, Interactions médicamenteuses)

Penicillin Because bacteriostatic drugs may interfere with the bactericidal action of penicillin, avoid giving EMROSI in conjunction with penicillin. (notice Minocycline, Interactions médicamenteuses)

Avoid concomitant use of isotretinoin and EMROSI because isotretinoin, a systemic retinoid, is also known to cause idiopathic intracranial hypertension. (notice Minocycline, Mises en garde et précautions)

Penicillin Because bacteriostatic drugs may interfere with the bactericidal action of penicillin, avoid giving EMROSI in conjunction with penicillin. (notice Minocycline, Interactions médicamenteuses)

Avoid concomitant use of isotretinoin and EMROSI because isotretinoin, a systemic retinoid, is also known to cause idiopathic intracranial hypertension. (notice Minocycline, Mises en garde et précautions)

Penicillin Because bacteriostatic drugs may interfere with the bactericidal action of penicillin, avoid giving EMROSI in conjunction with penicillin. (notice Minocycline, Interactions médicamenteuses)

Penicillin Because bacteriostatic drugs may interfere with the bactericidal action of penicillin, avoid giving EMROSI in conjunction with penicillin. (notice Minocycline, Interactions médicamenteuses)

Penicillin Because bacteriostatic drugs may interfere with the bactericidal action of penicillin, avoid giving EMROSI in conjunction with penicillin. (notice Minocycline, Interactions médicamenteuses)

Penicillin Because bacteriostatic drugs may interfere with the bactericidal action of penicillin, avoid giving EMROSI in conjunction with penicillin. (notice Minocycline, Interactions médicamenteuses)

Penicillin Because bacteriostatic drugs may interfere with the bactericidal action of penicillin, avoid giving EMROSI in conjunction with penicillin. (notice Minocycline, Interactions médicamenteuses)

EMROSI is contraindicated in patients with a history of hypersensitivity to any of the tetracyclines [see Warnings and Precautions (5.1) ]. (notice Minocycline, Contre-indications)

EMROSI is contraindicated in patients with a history of hypersensitivity to any of the tetracyclines [see Warnings and Precautions (5.1) ]. (notice Minocycline, Contre-indications)

Avoid concomitant use of isotretinoin and EMROSI because isotretinoin, a systemic retinoid, is also known to cause idiopathic intracranial hypertension. (notice Minocycline, Mises en garde et précautions)

Calcium acetate capsules may decrease the bioavailability of tetracyclines or fluoroquinolones via this mechanism. (notice Acétate de calcium, Interactions médicamenteuses)

Patients who are on anticoagulant therapy may require downward adjustment of their anticoagulant dosage. (notice Minocycline, Interactions médicamenteuses)

Patients who are on anticoagulant therapy may require downward adjustment of their anticoagulant dosage. (notice Minocycline, Interactions médicamenteuses)

• Concomitant administration of tetracycline reduces atovaquone concentrations; use caution when coadministering. (notice Atovaquone, Interactions médicamenteuses)

• Tetracycline may reduce atovaquone concentrations; parasitemia should be closely monitored. (notice Atovaquone et proguanil, Interactions médicamenteuses)

Patients who are on anticoagulant therapy may require downward adjustment of their anticoagulant dosage. (notice Minocycline, Interactions médicamenteuses)

Le calcium se lie à ces médicaments dans l'intestin et peut fortement réduire la quantité absorbée ; espacez les prises. (NIH Office of Dietary Supplements, Calcium)

The absorption of tetracycline, furosemide, penicillin G, hydrochlorothiazide, and gemfibrozil was significantly decreased when given simultaneously with colestipol hydrochloride; these drugs were not tested to determine the effect of administration one hour before colestipol hydrochloride. (notice Colestipol, Interactions médicamenteuses)

Drug Interactions Cholestyramine for Oral Suspension USP may delay or reduce the absorption of concomitant oral medication such as phenylbutazone, warfarin, thiazide diuretics (acidic), or propranolol (basic), as well as tetracycline, penicillin G, phenobarbital, thyroid and thyroxine preparations, estrogens and progestins, and digitalis. (notice Colestyramine, Interactions médicamenteuses)

Patients who are on anticoagulant therapy may require downward adjustment of their anticoagulant dosage. (notice Minocycline, Interactions médicamenteuses)

Patients who are on anticoagulant therapy may require downward adjustment of their anticoagulant dosage. (notice Minocycline, Interactions médicamenteuses)

Patients who are on anticoagulant therapy may require downward adjustment of their anticoagulant dosage. (notice Minocycline, Interactions médicamenteuses)

Le fer se lie à ces médicaments dans l'intestin et réduit leur absorption ; espacez les prises. (NIH Office of Dietary Supplements, Iron)

Patients who are on anticoagulant therapy may require downward adjustment of their anticoagulant dosage. (notice Minocycline, Interactions médicamenteuses)

…antagonists, fibrates, propoxyphene, pentoxifylline, somatostatin analogs, anabolic steroids and androgens, cyclophosphamide, phenyramidol, guanethidine, fluconazole, sulfinpyrazone, tetracyclines, clarithromycin, disopyramide, quinolones, and those drugs that are highly protein-bound, such as fluoxetine, nonsteroidal anti-inflammatory drugs, salicylates, sulfonamides,… (notice Glimépiride, Interactions médicamenteuses)

Patients who are on anticoagulant therapy may require downward adjustment of their anticoagulant dosage. (notice Minocycline, Interactions médicamenteuses)

Examples of relevant classes of compounds where antacids have been demonstrated to reduce bioavailability include antibiotics (such as quinolones, ampicillin, and tetracyclines), thyroid hormones, ACE inhibitors, statin lipid regulators, and anti-malarials. (notice Lanthane, Interactions médicamenteuses)

Caution should be exercised when JUXTAPID is used with other medications known to have potential for hepatotoxicity, such as isotretinoin, amiodarone, acetaminophen (>4 g/day for ≥3 days/week), methotrexate, tetracyclines, and tamoxifen. (notice Lomitapide, Mises en garde et précautions)

Les compléments et les antiacides contenant du magnésium réduisent l'absorption de ces médicaments ; espacez les prises d'au moins deux heures. (NIH Office of Dietary Supplements, Magnesium)

…antagonists, fibrates, propoxyphene, pentoxifylline, somatostatin analogs, anabolic steroids and androgens, cyclophosphamide, phenyramidol, guanethidine, fluconazole, sulfinpyrazone, tetracyclines, clarithromycin, disopyramide, quinolones, and those drugs that are highly protein-bound, such as fluoxetine, nonsteroidal anti-inflammatory drugs, salicylates, sulfonamides,… (notice Pioglitazone et glimépiride, Interactions médicamenteuses)

Tetracycline and other drugs that interact with magnesium Simultaneous administration of tetracycline with quinapril hydrochloride reduced the absorption of tetracycline by approximately 28% to 37%, possibly due to the high magnesium content in quinapril tablets. (notice Quinapril, Interactions médicamenteuses)

Although tetracycline may be concomitantly administered with quinine sulfate, patients should be monitored closely for adverse reactions associated with quinine sulfate. (notice Quinine, Interactions médicamenteuses)

Patients who are on anticoagulant therapy may require downward adjustment of their anticoagulant dosage. (notice Minocycline, Interactions médicamenteuses)

Antibiotics Drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as Rocuronium Bromide Injection include certain antibiotics (e.g., aminoglycosides; vancomycin; tetracyclines; bacitracin; polymyxins; colistin; and sodium colistimethate). (notice Rocuronium, Interactions médicamenteuses)

Drug Interactions Some studies have shown that simultaneous sucralfate administration in healthy volunteers reduced the extent of absorption (bioavailability) of single doses of the following: cimetidine, digoxin, fluoroquinolone antibiotics, ketoconazole, l-thyroxine, phenytoin, quinidine, ranitidine, tetracycline, and theophylline. (notice Sucralfate, Interactions médicamenteuses)

Patients who are on anticoagulant therapy may require downward adjustment of their anticoagulant dosage. (notice Minocycline, Interactions médicamenteuses)

Le zinc réduit l'absorption des antibiotiques de la famille des quinolones et des tétracyclines ; prenez l'antibiotique au moins deux heures avant ou quatre à six heures après le zinc. (NIH Office of Dietary Supplements, Zinc)

Antacids and Iron Preparations Absorption of tetracyclines is impaired by antacids containing aluminum, calcium or magnesium and iron-containing preparations. (notice Minocycline, Interactions médicamenteuses)

Antacids and Iron Preparations Absorption of tetracyclines is impaired by antacids containing aluminum, calcium or magnesium and iron-containing preparations. (notice Minocycline, Interactions médicamenteuses)

Antacids and Iron Preparations Absorption of tetracyclines is impaired by antacids containing aluminum, calcium or magnesium and iron-containing preparations. (notice Minocycline, Interactions médicamenteuses)

Antacids and Iron Preparations Absorption of tetracyclines is impaired by antacids containing aluminum, calcium or magnesium and iron-containing preparations. (notice Minocycline, Interactions médicamenteuses)

Antacids and Iron Preparations Absorption of tetracyclines is impaired by antacids containing aluminum, calcium or magnesium and iron-containing preparations. (notice Minocycline, Interactions médicamenteuses)

WARNINGS DEMECLOCYCLINE HYDROCHLORIDE, LIKE OTHER TETRACYCLINE-CLASS ANTIBIOTICS, CAN CAUSE FETAL HARM WHEN ADMINISTERED TO A PREGNANT WOMAN. (notice Déméclocycline, Mises en garde)

A similar association, though less marked, has been suggested for barbiturates, phenylbutazone, phenytoin sodium, and possibly with griseofulvin, ampicillin, and tetracyclines. (notice Diacétate d'étynodiol et éthinylestradiol, Interactions médicamenteuses)

EMROSI may induce hyperpigmentation in many organs, including nails, bone, skin, eyes, thyroid, visceral tissue, oral cavity (teeth, mucosa, alveolar bone), sclerae and heart valves. (notice Minocycline, Mises en garde et précautions)

EMROSI may induce hyperpigmentation in many organs, including nails, bone, skin, eyes, thyroid, visceral tissue, oral cavity (teeth, mucosa, alveolar bone), sclerae and heart valves. (notice Minocycline, Mises en garde et précautions)

EMROSI may induce hyperpigmentation in many organs, including nails, bone, skin, eyes, thyroid, visceral tissue, oral cavity (teeth, mucosa, alveolar bone), sclerae and heart valves. (notice Minocycline, Mises en garde et précautions)

Antacids and Iron Preparations Absorption of tetracyclines is impaired by antacids containing aluminum, calcium or magnesium and iron-containing preparations. (notice Minocycline, Interactions médicamenteuses)

EMROSI may induce hyperpigmentation in many organs, including nails, bone, skin, eyes, thyroid, visceral tissue, oral cavity (teeth, mucosa, alveolar bone), sclerae and heart valves. (notice Minocycline, Mises en garde et précautions)

EMROSI may induce hyperpigmentation in many organs, including nails, bone, skin, eyes, thyroid, visceral tissue, oral cavity (teeth, mucosa, alveolar bone), sclerae and heart valves. (notice Minocycline, Mises en garde et précautions)

EMROSI may induce hyperpigmentation in many organs, including nails, bone, skin, eyes, thyroid, visceral tissue, oral cavity (teeth, mucosa, alveolar bone), sclerae and heart valves. (notice Minocycline, Mises en garde et précautions)

The following antibiotics have been associated with various degrees of paralysis: aminoglycosides (such as neomycin, streptomycin, kanamycin, gentamicin, and dihydrostreptomycin); tetracyclines; bacitracin; polymyxin B; colistin; and sodium colistimethate. (notice Vécuronium, Précautions)

…omeprazole prednisone, prednisolone ranitidine rifabutin roxithromycin sorbitol (purgative doses do not inhibit theophylline absorption) sucralfate terbutaline, systemic terfenadine tetracycline tocainide The Effect of Other Drugs on Theophylline Serum Concentration Measurements: Most serum theophylline assays in clinical use are immunoassays which are specific… (notice Aminophylline, Interactions médicamenteuses)

…additional doses of Cisatracurium Besylate Injection, and to determine whether adjustments need to be made to the dose with subsequent administration. † Examples: aminoglycosides, tetracyclines, bacitracin, polymyxins, lincomycin, clindamycin, colistin, sodium colistimethate Drug or Drug Class Clinical Implications * Succinylcholine The use of succinylcholine… (notice Cisatracurium, Interactions médicamenteuses)

…ranitidine famotidine rifabutin felodipine roxithromycin finasteride Sorbitol (purgative doses do not inhibit hydrocortisone theophylline absorption) isoflurane sucralfate isoniazid terbutaline, systemic isradipine terfenadine influenza vaccine tetracycline ketoconazole tocainide lomefloxacin * Refer to PRECAUTIONS , Drug Interactions for information regarding table. (notice Théophylline, Interactions médicamenteuses)